Cargando…
Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
Since the discovery of messenger RNA (mRNA), there have been tremendous efforts to wield them in the development of therapeutics and vaccines. During the COVID-19 pandemic, two mRNA vaccines were developed and approved in record-breaking time, revolutionizing the vaccine development landscape. Altho...
Autores principales: | Lee, Jisun, Woodruff, Matthew C., Kim, Eui Ho, Nam, Jae-Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394010/ https://www.ncbi.nlm.nih.gov/pubmed/37430088 http://dx.doi.org/10.1038/s12276-023-00999-x |
Ejemplares similares
-
25. Immunogenicity and Reactogenicity of COVID-19 mRNA Vaccines in Allogeneic Stem Cell Transplant Recipients
por: Bausk, Bruce P, et al.
Publicado: (2021) -
1639. A Review of Clinical Safety, Reactogenicity, and Immunogenicity of an mRNA-Based Seasonal Influenza Vaccine (mRNA-1010) in Adults
por: Soens, Mieke, et al.
Publicado: (2023) -
Methods for predicting vaccine immunogenicity and reactogenicity
por: Gonzalez-Dias, Patrícia, et al.
Publicado: (2019) -
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination
por: Schmidt, Tina, et al.
Publicado: (2021) -
Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine
por: Takano, Tomohiro, et al.
Publicado: (2022)